In patients with COVID-19, adding thymalin to standard therapy accelerated the decline in IL-6, C-reactive protein and D-dimer compared with standard therapy.
In plain wordsIn patients with COVID-19, thymalin with standard therapy lowered IL-6, C-reactive protein and D-dimer faster than standard therapy alone.
- Peptide
- Thymalin
- Outcome
- DecreaseDecline in IL-6, C-reactive protein and D-dimer
- Study
n: not reported in source
- Comparator
- Standard therapy
- Outcome group
- Inflammation markers · Immune and inflammation
- Studied dose
- Dose not stated
Source sentences
The addition of thymalin to standard therapy accelerated the decline in both these indicators and the indicators of the T cell system.
2 context sentences(design, population, supporting numbers)
It was found that, as a result of standard treatment, patients in the control group showed a decrease in the concentration of the pro-inflammatory cytokine IL-6, C-reactive protein, D-dimer.
The paper presents the results of a standard and complex treatment method using the peptide drug thymus thymalin in patients with COVID-19.